This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.
Study Type
OBSERVATIONAL
Enrollment
510
Hospital Clinico Universitario Lozano Blesa
Zaragoza, Aragon, Spain
RECRUITINGHospital Universitario de Cruces
Bilbao, Basque Country, Spain
RECRUITINGClinical Validation
To clinically validate the diagnostic capability of the algorithm for early detection of CRC and AA that combines molecular markers and risk factors
Time frame: 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Policlinica Gipuzkoa Hospital
Donostia / San Sebastian, Basque Country, Spain
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain
TERMINATEDHospital Universitario de Salamanca
Salamanca, Castille and León, Spain
RECRUITINGHospital Sant Rafael
Barcelona, Catalonia, Spain
COMPLETEDHospital Universitario Vall d' Hebron
Barcelona, Catalonia, Spain
COMPLETEDMD Anderson Cancer Centre
Madrid, Madrid, Spain
ACTIVE_NOT_RECRUITINGHospital Centro Médico de Asturias
Oviedo, Principality of Asturias, Spain
RECRUITING